Magic mushroom therapy could ease lingering concussion woes
NCT ID NCT06615908
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This early-stage study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can safely help people aged 18-65 with concussion symptoms lasting over 3 months. Forty participants will receive either a high or low dose of psilocybin, plus weekly therapy sessions. The main goals are to check safety and see if the approach is practical and promising for reducing symptom burden.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT POST-CONCUSSIVE SYMPTOMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 2T9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.